Multiple Sclerosis. Multiple Sclerosis
Conditions
Interventions
Intervention 1: Intervention group: In-Person Transdiagnostic Cognitive-Behavioral Therapy (Unified Protocol)** The intervention will be delivered in person using the Transdiagnostic Cognitive-Behavi
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Diagnosis of Multiple Sclerosis Minimum literacy level (at least middle school education) No history of addiction No other psychological treatments received during the study Age between 20 and 40 years No acute psychiatric disorders No severe physical disability, such as dependence on a wheelchair Score between 0 and 16 on the BDI-II (Beck Depression Inventory-II) Score between 0 and 25 on the BAI (Beck Anxiety Inventory)
Exclusion criteria
Exclusion criteria: Development of severe psychiatric disorders Relapse of the disease or severe physical disability Development of severe physical disability (such as wheelchair dependence) during the study Absence from more than two sessions Recent experience of an acute psychological crisis Score higher than 16 on the BDI-II Score higher than 25 on the BAI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fear of Disease Progression. Timepoint: Measurements will be conducted at three time points: before the intervention (baseline), immediately after the intervention completion (post-treatment), and three months after the intervention completion (3-month follow-up). Method of measurement: The individual's score on the Fear of Disease Progression Questionnaire (FoP-Q).;Perceived Stress. Timepoint: Measurements will be conducted at three time points: before the intervention (baseline), immediately after the intervention completion (post-treatment), and three months after the intervention completion (3-month follow-up). Method of measurement: The participant's score on the Cohen Perceived Stress Scale (PSS).;Intolerance of Uncertainty. Timepoint: Measurements will be conducted at three time points: before the intervention (baseline), immediately after the intervention completion (post-treatment), and three months after the intervention completion (3-month follow-up). Method of measurement: The respondent's Intolerance of Uncertainty Scale (IUS) score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depresion. Timepoint: Measurements will be conducted at three time points: before the intervention (baseline), immediately after the intervention completion (post-treatment), and three months after the intervention completion (3-month follow-up). Method of measurement: BDI Questionnaire score.;Anxiety. Timepoint: Measurements will be conducted at three time points: before the intervention (baseline), immediately after the intervention completion (post-treatment), and three months after the intervention completion (3-month follow-up). Method of measurement: BAI Questionnaire score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElahe karami
Zanjan University of Medical Sciences
Outcome results
None listed